BCAR3 antibody (C-Term)
Quick Overview for BCAR3 antibody (C-Term) (ABIN7184617)
Target
See all BCAR3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- BCAR3 Antibody
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human BCAR3.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- BCAR3 (Breast Cancer Anti-Estrogen Resistance 3 (BCAR3))
-
Alternative Name
- BCAR3
-
Background
- BCAR 3 antibody, BCAR3 antibody, BCAR3_HUMAN antibody, Breast cancer anti estrogen resistance 3 antibody, Breast cancer anti estrogen resistance protein 3 antibody, Breast cancer anti-estrogen resistance protein 3 antibody, Breast cancer antiestrogen resistance 3 antibody, dJ1033H22.2 antibody, dJ1033H22.2 breast cancer anti estrogen resistance 3 antibody, dJ1033H22.2 breast cancer antiestrogen resistance 3 antibody, KIAA0554 antibody, Novel SH2 containing protein 2 antibody, Novel SH2-containing protein 2 antibody, NSP 2 antibody, NSP2 antibody, SH2 containing protein Nsp2 antibody, SH2 domain containing protein 3B antibody, SH2 domain-containing protein 3B antibody, SH2D3B antibody
-
UniProt
- O75815
Target
-